

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 9.60549381 |
| 2 | cytidine catabolic process (GO:0006216) | 9.60549381 |
| 3 | cytidine deamination (GO:0009972) | 9.60549381 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.71920739 |
| 5 | DNA deamination (GO:0045006) | 8.38779569 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.19684351 |
| 7 | negative regulation by host of viral transcription (GO:0043922) | 6.22108906 |
| 8 | eosinophil chemotaxis (GO:0048245) | 4.87165361 |
| 9 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.78120082 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.67249283 |
| 11 | cytolysis (GO:0019835) | 4.54243665 |
| 12 | eosinophil migration (GO:0072677) | 4.40218182 |
| 13 | positive regulation of T cell apoptotic process (GO:0070234) | 4.38301027 |
| 14 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.38259998 |
| 15 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.33835046 |
| 16 | actin nucleation (GO:0045010) | 4.23200483 |
| 17 | positive T cell selection (GO:0043368) | 4.15957716 |
| 18 | negative regulation of T cell apoptotic process (GO:0070233) | 4.15777893 |
| 19 | positive thymic T cell selection (GO:0045059) | 4.08345840 |
| 20 | regulation of regulatory T cell differentiation (GO:0045589) | 4.05387645 |
| 21 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.05149486 |
| 22 | DNA demethylation (GO:0080111) | 4.03176781 |
| 23 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.00806940 |
| 24 | negative regulation of viral transcription (GO:0032897) | 3.90254837 |
| 25 | regulation of activation of Janus kinase activity (GO:0010533) | 3.89579461 |
| 26 | positive regulation of tolerance induction (GO:0002645) | 3.87554229 |
| 27 | regulation of chronic inflammatory response (GO:0002676) | 3.87310556 |
| 28 | macrophage chemotaxis (GO:0048246) | 3.83968724 |
| 29 | regulation of T cell chemotaxis (GO:0010819) | 3.82775117 |
| 30 | positive regulation of T cell chemotaxis (GO:0010820) | 3.82775117 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.70188765 |
| 32 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.68281047 |
| 33 | regulation of interleukin-8 secretion (GO:2000482) | 3.61097843 |
| 34 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.56042170 |
| 35 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.56042170 |
| 36 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.55378460 |
| 37 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.50819429 |
| 38 | negative regulation of viral genome replication (GO:0045071) | 3.49218869 |
| 39 | DNA dealkylation (GO:0035510) | 3.48759281 |
| 40 | modulation by host of symbiont transcription (GO:0052472) | 3.47764202 |
| 41 | modulation by host of viral transcription (GO:0043921) | 3.47764202 |
| 42 | positive regulation of lymphocyte migration (GO:2000403) | 3.47125024 |
| 43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.43883467 |
| 44 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.42316207 |
| 45 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.40943199 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.40094590 |
| 47 | regulation of T cell tolerance induction (GO:0002664) | 3.38869065 |
| 48 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 3.34240856 |
| 49 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.30435848 |
| 50 | positive regulation of defense response to virus by host (GO:0002230) | 3.24150729 |
| 51 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.21707267 |
| 52 | positive regulation of cell killing (GO:0031343) | 3.16183748 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.10617298 |
| 54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.08559802 |
| 55 | negative regulation of ligase activity (GO:0051352) | 3.08559802 |
| 56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.07783093 |
| 57 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.07409849 |
| 58 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.07409849 |
| 59 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.07409849 |
| 60 | T cell costimulation (GO:0031295) | 3.06279145 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05334908 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.02929492 |
| 63 | rRNA transcription (GO:0009303) | 3.02913760 |
| 64 | lymphocyte costimulation (GO:0031294) | 3.02446209 |
| 65 | regulation of T cell apoptotic process (GO:0070232) | 3.02277619 |
| 66 | organic cation transport (GO:0015695) | 3.00969334 |
| 67 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.99426767 |
| 68 | negative regulation of B cell activation (GO:0050869) | 2.99282854 |
| 69 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.96498861 |
| 70 | negative regulation of B cell mediated immunity (GO:0002713) | 2.96498861 |
| 71 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.96466414 |
| 72 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.96466414 |
| 73 | labyrinthine layer development (GO:0060711) | 2.90936766 |
| 74 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.90293705 |
| 75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.90293705 |
| 76 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87658245 |
| 77 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.86350780 |
| 78 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.86336821 |
| 79 | regulation of calcium-mediated signaling (GO:0050848) | 2.85985027 |
| 80 | ribosomal small subunit assembly (GO:0000028) | 2.85637500 |
| 81 | phagocytosis, recognition (GO:0006910) | 2.85155429 |
| 82 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84314051 |
| 83 | thymic T cell selection (GO:0045061) | 2.84286345 |
| 84 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82878798 |
| 85 | regulation of meiosis I (GO:0060631) | 2.82232348 |
| 86 | proteasome assembly (GO:0043248) | 2.81910756 |
| 87 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.81733742 |
| 88 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.81733742 |
| 89 | regulation of tolerance induction (GO:0002643) | 2.80932241 |
| 90 | negative regulation of viral process (GO:0048525) | 2.80252227 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.79400519 |
| 92 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.79293160 |
| 93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78868452 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 2.78301174 |
| 95 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.76273423 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.72722622 |
| 97 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.72499269 |
| 98 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.72208454 |
| 99 | regulation of cell killing (GO:0031341) | 2.72047409 |
| 100 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.69710286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.14648690 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.61509047 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.05041948 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.27029765 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.93238092 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.90787612 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.77114940 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.71480942 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.55969733 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.45112930 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.42936797 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.41923929 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41907116 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.30706143 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.28262996 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.27520676 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.21195429 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.11374579 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.92642693 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.90058130 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.87510542 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.83719890 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83025718 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.79176417 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77214932 |
| 26 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.77079305 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.73258155 |
| 28 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.71470111 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70792967 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62900059 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58595523 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58390969 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58122145 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55402497 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53862998 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53247668 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46904211 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46628205 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46256512 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.43002774 |
| 41 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.39766802 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.39163675 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35437826 |
| 44 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.32836900 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32758810 |
| 46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30859541 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30484859 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29592065 |
| 49 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25502367 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.24001710 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.24001710 |
| 52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23329241 |
| 53 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.21193076 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19386292 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18625328 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17847897 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15749667 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13426309 |
| 59 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12862657 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12486790 |
| 61 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11223740 |
| 62 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10228224 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09866224 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09866224 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09187923 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07067895 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06253467 |
| 68 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.06060058 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05812102 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05744652 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05469428 |
| 72 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.05060575 |
| 73 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04961064 |
| 74 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04675318 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.04487818 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03335366 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02591200 |
| 78 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00726401 |
| 79 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99378403 |
| 80 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99090615 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.99049440 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.98920969 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98124806 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96319614 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96319614 |
| 86 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95069413 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94875521 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94374135 |
| 89 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92449448 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.92354741 |
| 91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92220933 |
| 92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92068035 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89969425 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87230281 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87013941 |
| 96 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86435132 |
| 97 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85701023 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84383038 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83498545 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83309383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.44580303 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 4.44243894 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 3.63737504 |
| 4 | MP0004147_increased_porphyrin_level | 3.35744498 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.28721509 |
| 6 | MP0004381_abnormal_hair_follicle | 2.77861199 |
| 7 | MP0003786_premature_aging | 2.77553941 |
| 8 | MP0001873_stomach_inflammation | 2.71877258 |
| 9 | MP0002132_abnormal_respiratory_system | 2.50679070 |
| 10 | MP0009785_altered_susceptibility_to | 2.45327633 |
| 11 | MP0006082_CNS_inflammation | 2.42770317 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.41750942 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.22070351 |
| 14 | MP0002006_tumorigenesis | 2.20014990 |
| 15 | MP0001188_hyperpigmentation | 2.12932967 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.04364229 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 1.97525105 |
| 18 | MP0003866_abnormal_defecation | 1.97519008 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 1.91146138 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.81909655 |
| 21 | MP0001790_abnormal_immune_system | 1.76859063 |
| 22 | MP0005387_immune_system_phenotype | 1.76859063 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.76241023 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.75951772 |
| 25 | MP0001800_abnormal_humoral_immune | 1.70284420 |
| 26 | MP0001727_abnormal_embryo_implantation | 1.69242713 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.68850278 |
| 28 | MP0001819_abnormal_immune_cell | 1.62546829 |
| 29 | MP0002163_abnormal_gland_morphology | 1.62539801 |
| 30 | MP0001853_heart_inflammation | 1.60856762 |
| 31 | MP0001661_extended_life_span | 1.59636919 |
| 32 | MP0002398_abnormal_bone_marrow | 1.57141799 |
| 33 | MP0005310_abnormal_salivary_gland | 1.56710581 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.56116989 |
| 35 | MP0002723_abnormal_immune_serum | 1.55580896 |
| 36 | MP0005025_abnormal_response_to | 1.52942170 |
| 37 | MP0000716_abnormal_immune_system | 1.51769564 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.51166855 |
| 39 | MP0002405_respiratory_system_inflammati | 1.47875232 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.47479642 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.46937393 |
| 42 | MP0003283_abnormal_digestive_organ | 1.44436263 |
| 43 | MP0002722_abnormal_immune_system | 1.40226917 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.39290046 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.36571132 |
| 46 | MP0003448_altered_tumor_morphology | 1.32169918 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.30662752 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.29830621 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.28503281 |
| 50 | MP0000685_abnormal_immune_system | 1.25866674 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24440762 |
| 52 | MP0006292_abnormal_olfactory_placode | 1.19227522 |
| 53 | MP0008995_early_reproductive_senescence | 1.16790829 |
| 54 | MP0002429_abnormal_blood_cell | 1.16340757 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.15992748 |
| 56 | MP0003878_abnormal_ear_physiology | 1.15992748 |
| 57 | MP0003195_calcinosis | 1.13706594 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.11962935 |
| 59 | MP0004858_abnormal_nervous_system | 1.11900658 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.09172428 |
| 61 | MP0001984_abnormal_olfaction | 1.08854544 |
| 62 | MP0004947_skin_inflammation | 1.08505361 |
| 63 | MP0001542_abnormal_bone_strength | 1.02548864 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.01546356 |
| 65 | MP0000647_abnormal_sebaceous_gland | 1.01003111 |
| 66 | MP0008058_abnormal_DNA_repair | 1.00795021 |
| 67 | MP0003646_muscle_fatigue | 1.00094585 |
| 68 | MP0004484_altered_response_of | 0.97088045 |
| 69 | MP0005083_abnormal_biliary_tract | 0.94715397 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.93393463 |
| 71 | MP0002933_joint_inflammation | 0.93267289 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.90943997 |
| 73 | MP0004145_abnormal_muscle_electrophysio | 0.88555647 |
| 74 | MP0004134_abnormal_chest_morphology | 0.88252780 |
| 75 | MP0005646_abnormal_pituitary_gland | 0.87785852 |
| 76 | MP0004142_abnormal_muscle_tone | 0.84529886 |
| 77 | MP0008770_decreased_survivor_rate | 0.83851420 |
| 78 | MP0003252_abnormal_bile_duct | 0.83005337 |
| 79 | MP0003045_fibrosis | 0.82556392 |
| 80 | MP0002735_abnormal_chemical_nociception | 0.78941632 |
| 81 | MP0005423_abnormal_somatic_nervous | 0.76870670 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.75577261 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.75319142 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.73999045 |
| 85 | MP0001905_abnormal_dopamine_level | 0.73819869 |
| 86 | MP0002160_abnormal_reproductive_system | 0.73247655 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.72972081 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 0.72737272 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.71505822 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 0.71305063 |
| 91 | MP0008873_increased_physiological_sensi | 0.70428414 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.68086204 |
| 93 | MP0005360_urolithiasis | 0.67036028 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.64369034 |
| 95 | MP0002733_abnormal_thermal_nociception | 0.62796974 |
| 96 | MP0002928_abnormal_bile_duct | 0.61001282 |
| 97 | MP0005330_cardiomyopathy | 0.59925234 |
| 98 | MP0005253_abnormal_eye_physiology | 0.57500096 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.57468804 |
| 100 | MP0003111_abnormal_nucleus_morphology | 0.57431005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.85150219 |
| 2 | 3-Methylglutaconic aciduria (HP:0003535) | 4.59745688 |
| 3 | T lymphocytopenia (HP:0005403) | 4.21209368 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.16158217 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 4.02441727 |
| 6 | Aplastic anemia (HP:0001915) | 3.99522457 |
| 7 | Pancreatic cysts (HP:0001737) | 3.68502905 |
| 8 | Hypoproteinemia (HP:0003075) | 3.64322342 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.51889905 |
| 10 | Large eyes (HP:0001090) | 3.40123255 |
| 11 | Increased IgM level (HP:0003496) | 3.35800969 |
| 12 | Encephalitis (HP:0002383) | 3.29820596 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.28754670 |
| 14 | True hermaphroditism (HP:0010459) | 3.21352942 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.15269746 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.14757956 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.14048152 |
| 18 | Cerebellar dysplasia (HP:0007033) | 2.97789298 |
| 19 | Abnormality of the prostate (HP:0008775) | 2.96399499 |
| 20 | Congenital stationary night blindness (HP:0007642) | 2.95485544 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 2.84836764 |
| 22 | Increased CSF lactate (HP:0002490) | 2.82402134 |
| 23 | Abnormality of T cells (HP:0002843) | 2.81907937 |
| 24 | Hepatocellular necrosis (HP:0001404) | 2.69718845 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.69684690 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.69684690 |
| 27 | Pancreatic fibrosis (HP:0100732) | 2.67741861 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 2.65984017 |
| 29 | Chronic otitis media (HP:0000389) | 2.65942299 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.65082989 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 2.54419172 |
| 32 | Hyperalaninemia (HP:0003348) | 2.54419172 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.54419172 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.52677765 |
| 35 | IgG deficiency (HP:0004315) | 2.52296806 |
| 36 | Abnormality of eosinophils (HP:0001879) | 2.51520220 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50052720 |
| 38 | Eosinophilia (HP:0001880) | 2.47362007 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 2.47361016 |
| 40 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.45724204 |
| 41 | Meningitis (HP:0001287) | 2.38615397 |
| 42 | Hepatic necrosis (HP:0002605) | 2.37877706 |
| 43 | Increased serum lactate (HP:0002151) | 2.35639650 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.34764117 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.34764117 |
| 46 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.34764117 |
| 47 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.34764117 |
| 48 | Optic disc pallor (HP:0000543) | 2.29291086 |
| 49 | Hemiplegia (HP:0002301) | 2.26300047 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.25656245 |
| 51 | Exertional dyspnea (HP:0002875) | 2.24236105 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.23636257 |
| 53 | Chronic sinusitis (HP:0011109) | 2.23413106 |
| 54 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21189331 |
| 55 | Renal cortical cysts (HP:0000803) | 2.20938412 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.20522002 |
| 57 | Glycosuria (HP:0003076) | 2.20522002 |
| 58 | Clubbing of toes (HP:0100760) | 2.16766242 |
| 59 | Chest pain (HP:0100749) | 2.16098083 |
| 60 | Progressive macrocephaly (HP:0004481) | 2.13621854 |
| 61 | Abnormality of the pleura (HP:0002103) | 2.13548198 |
| 62 | Nephronophthisis (HP:0000090) | 2.12968422 |
| 63 | Acute encephalopathy (HP:0006846) | 2.09042082 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.08282518 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.08282518 |
| 66 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04557142 |
| 67 | Myositis (HP:0100614) | 2.02567775 |
| 68 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.01548549 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.01116820 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.01116077 |
| 71 | Lymphoma (HP:0002665) | 2.00053592 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 1.97134937 |
| 73 | Optic neuritis (HP:0100653) | 1.97134937 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 1.96009138 |
| 75 | Microretrognathia (HP:0000308) | 1.94552650 |
| 76 | Prostate neoplasm (HP:0100787) | 1.93101377 |
| 77 | Gait imbalance (HP:0002141) | 1.92552485 |
| 78 | Granulocytopenia (HP:0001913) | 1.91835372 |
| 79 | Pancytopenia (HP:0001876) | 1.91721888 |
| 80 | Abnormality of renal resorption (HP:0011038) | 1.91018610 |
| 81 | Congenital primary aphakia (HP:0007707) | 1.90883786 |
| 82 | Failure to thrive in infancy (HP:0001531) | 1.88564695 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 1.87988690 |
| 84 | Hemoptysis (HP:0002105) | 1.84579984 |
| 85 | Gangrene (HP:0100758) | 1.84434006 |
| 86 | Type II lissencephaly (HP:0007260) | 1.83736908 |
| 87 | Cystic liver disease (HP:0006706) | 1.83674970 |
| 88 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83456627 |
| 89 | Ureteral stenosis (HP:0000071) | 1.83372685 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 1.82998770 |
| 91 | Microcytic anemia (HP:0001935) | 1.82610048 |
| 92 | Abnormality of male internal genitalia (HP:0000022) | 1.82034991 |
| 93 | Lactic acidosis (HP:0003128) | 1.80762825 |
| 94 | Cerebral edema (HP:0002181) | 1.80363608 |
| 95 | Erythema (HP:0010783) | 1.80204104 |
| 96 | Combined immunodeficiency (HP:0005387) | 1.79985175 |
| 97 | Sclerocornea (HP:0000647) | 1.79899475 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76095807 |
| 99 | Obstructive lung disease (HP:0006536) | 1.76095807 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75619912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 5.84812834 |
| 2 | TXK | 5.76031053 |
| 3 | KDR | 4.79241847 |
| 4 | TAOK3 | 3.56020679 |
| 5 | PBK | 3.33393183 |
| 6 | BUB1 | 2.81385880 |
| 7 | BMPR1B | 2.30066595 |
| 8 | TLK1 | 2.23294364 |
| 9 | SCYL2 | 2.20855343 |
| 10 | TESK2 | 2.20690807 |
| 11 | VRK1 | 2.13814491 |
| 12 | BCKDK | 2.10162873 |
| 13 | ITK | 2.07482822 |
| 14 | STK16 | 2.00766768 |
| 15 | BRSK2 | 1.74192894 |
| 16 | FRK | 1.66433291 |
| 17 | ADRBK2 | 1.60359662 |
| 18 | MST4 | 1.55665055 |
| 19 | WNK4 | 1.42443767 |
| 20 | MARK3 | 1.39513610 |
| 21 | NUAK1 | 1.34667800 |
| 22 | MAP4K2 | 1.33549197 |
| 23 | PRKCQ | 1.29569389 |
| 24 | MAP3K5 | 1.27417772 |
| 25 | VRK2 | 1.25935930 |
| 26 | GRK1 | 1.22956207 |
| 27 | PLK4 | 1.19158772 |
| 28 | MAP4K1 | 1.09546875 |
| 29 | IKBKB | 1.09452177 |
| 30 | MAP2K6 | 1.08324070 |
| 31 | MATK | 1.03545444 |
| 32 | WEE1 | 0.99347301 |
| 33 | LCK | 0.95451338 |
| 34 | CDK12 | 0.91238698 |
| 35 | MAP3K12 | 0.87596166 |
| 36 | TEC | 0.86585258 |
| 37 | IRAK1 | 0.85954319 |
| 38 | GRK7 | 0.82808820 |
| 39 | CHUK | 0.82145241 |
| 40 | ACVR1B | 0.75129975 |
| 41 | PRKCH | 0.73574795 |
| 42 | SYK | 0.73568359 |
| 43 | BMPR2 | 0.73372668 |
| 44 | DAPK1 | 0.73367125 |
| 45 | PASK | 0.71149119 |
| 46 | PIM1 | 0.69021397 |
| 47 | MYLK | 0.68288360 |
| 48 | CDK19 | 0.66695085 |
| 49 | AKT3 | 0.66151322 |
| 50 | MAPKAPK3 | 0.65973022 |
| 51 | TAF1 | 0.65501009 |
| 52 | PRKD3 | 0.61310404 |
| 53 | MAPK13 | 0.60544050 |
| 54 | SRPK1 | 0.58659031 |
| 55 | MAP2K7 | 0.57754992 |
| 56 | NTRK1 | 0.56568201 |
| 57 | ZAP70 | 0.54803237 |
| 58 | BTK | 0.53516860 |
| 59 | TIE1 | 0.50594440 |
| 60 | PLK3 | 0.50220258 |
| 61 | ATR | 0.49330620 |
| 62 | RPS6KA5 | 0.48500283 |
| 63 | PIK3CG | 0.48333892 |
| 64 | JAK3 | 0.48251473 |
| 65 | LYN | 0.48089889 |
| 66 | PKN1 | 0.47590329 |
| 67 | INSRR | 0.46611513 |
| 68 | WNK3 | 0.46090036 |
| 69 | PIK3CA | 0.45549960 |
| 70 | AURKA | 0.45258732 |
| 71 | DYRK1A | 0.45211061 |
| 72 | GRK5 | 0.44130730 |
| 73 | LIMK1 | 0.42639247 |
| 74 | PLK2 | 0.42399629 |
| 75 | TTK | 0.42039522 |
| 76 | CHEK2 | 0.40559415 |
| 77 | OXSR1 | 0.39962411 |
| 78 | TNK2 | 0.38897493 |
| 79 | ADRBK1 | 0.38565334 |
| 80 | DYRK1B | 0.35151726 |
| 81 | MUSK | 0.34937651 |
| 82 | DYRK2 | 0.34487533 |
| 83 | ERBB2 | 0.34026983 |
| 84 | INSR | 0.32440408 |
| 85 | BRD4 | 0.32186976 |
| 86 | CSNK1G3 | 0.32185068 |
| 87 | PAK1 | 0.31628289 |
| 88 | PINK1 | 0.31361898 |
| 89 | PLK1 | 0.30765451 |
| 90 | CDK9 | 0.30511295 |
| 91 | BRSK1 | 0.29104678 |
| 92 | CAMK2A | 0.26743210 |
| 93 | ABL2 | 0.26163976 |
| 94 | OBSCN | 0.25475755 |
| 95 | CCNB1 | 0.25356309 |
| 96 | FYN | 0.23304268 |
| 97 | PRKACA | 0.22281925 |
| 98 | TRIM28 | 0.22218911 |
| 99 | CSK | 0.21633374 |
| 100 | TYRO3 | 0.21482447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.93773602 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.43031495 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.36663254 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.14049005 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.82572697 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.67708492 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63758418 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.63324768 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.40735050 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.21364545 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.18739463 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12963875 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03149198 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.02207482 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 2.00930350 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.93916943 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.81215473 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76915015 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.69819179 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61432811 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.57872337 |
| 22 | Alcoholism_Homo sapiens_hsa05034 | 1.55002990 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.45097366 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.41408794 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28083428 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.24094731 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19241425 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.15782173 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15069779 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.11480890 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06147800 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05806797 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05618774 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05255470 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05151631 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.04792964 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04570256 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02716565 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98051439 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94622337 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94132921 |
| 42 | Spliceosome_Homo sapiens_hsa03040 | 0.92997573 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92925285 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92501831 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91562860 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91044824 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.88614159 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88075170 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.85846587 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.82597371 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82318078 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81715191 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 0.80249109 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79326731 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79244775 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78236110 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 0.72234480 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70999673 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69790353 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.67411833 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.67126258 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62359643 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59881406 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59276680 |
| 65 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59246345 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.57458058 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56785980 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55209199 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55172905 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52819859 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50420465 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49543000 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49372865 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47815222 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47297747 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47043205 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46845201 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45873600 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45802058 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45288777 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.45241110 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44767311 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44297351 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43833277 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43411822 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43220672 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.40019558 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.39115337 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37934768 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36556619 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34102477 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33825411 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31791701 |
| 94 | Nicotine addiction_Homo sapiens_hsa05033 | 0.28583413 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25425610 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23737194 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23058894 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.22712372 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22604704 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21225647 |

